Daniel Lynch

Daniel Lynch

Voorzitter bij SPRINGWORKS THERAPEUTICS, INC.

Vermogen: 14 M $ op 30-04-2024

65 jaar
Health Technology
Finance
Health Services

Oorsprong van het eerstegraads netwerk van Daniel Lynch

EntiteitType entiteitIndustrie
Public Company Pharmaceuticals: Major 186
Wesleyan University
77
College/University Other Consumer Services 77
73
Subsidiary Investment Managers 73
Public Company Biotechnology 62
Extinct Pharmaceuticals: Major 33
28
Subsidiary Biotechnology 28
Public Company Biotechnology 26
Subsidiary Biotechnology 26
Public Company Biotechnology 25
25
Subsidiary Medical/Nursing Services 25
Public Company Pharmaceuticals: Major 19
Private Company Biotechnology 19
University of Virginia Darden School of Business
17
College/University Other Consumer Services 17
Public Company Pharmaceuticals: Major 16
Subsidiary Biotechnology 13
8
Subsidiary Biotechnology 8
Private Company Financial Conglomerates 7
6
Subsidiary Pharmaceuticals: Major 6
3
Extinct Pharmaceuticals: Major 3
1
Subsidiary Pharmaceuticals: Major 1
1
Private Company Real Estate Development 1
1
Holding Company Biotechnology 1

Grafiek van bedrijven verbonden in de tweede graad

Connectie in verschillende bedrijven

Bedrijven verbonden met Daniel Lynch via zijn persoonlijke netwerk

OndernemingSectorGelieerde personenHoofdpost
The Wharton School of the University of Pennsylvania College/University

Nick Leschly

Cary Pfeffer

Chip Baird

Kyle Kuvalanka

Daniel Curran

Jeffrey Schwartz

Elisabeth Leiderman

Lara Sullivan

Masters Business Admin

Masters Business Admin

Masters Business Admin

Masters Business Admin

Masters Business Admin

Masters Business Admin

Masters Business Admin

Masters Business Admin

University of Pennsylvania College/University

Mark Sullivan

Cary Pfeffer

Andrew Hirsch

Tracey McCain

Elisabeth Leiderman

Marcela Maus

Undergraduate Degree

Doctorate Degree

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Doctorate Degree

Harvard Medical School College/University

Freda Lewis-Hall

Mark Goldberg

Robert Ross

William R. Sellers

Wei Lin

Marcela Maus

Director/Board Member

Doctorate Degree

Graduate Degree

Corporate Officer/Principal

Doctorate Degree

Corporate Officer/Principal

Pharmaceuticals: Major

David Schenkein

Abbie Celniker

Kyle Kuvalanka

Daniel Curran

Anthony Boral

Corporate Officer/Principal

Chief Operating Officer

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Biotechnology

David Schenkein

Abbie Celniker

Martin Babler

Julie Hambleton

Wei Lin

Corporate Officer/Principal

Corporate Officer/Principal

Sales & Marketing

Corporate Officer/Principal

Corporate Officer/Principal

BIOGEN INC. Pharmaceuticals: Major

Eric Rowinsky

Gina Consylman

Paul Clancy

Andrew Hirsch

Liisa I. Nogelo

Director/Board Member

Director/Board Member

Director of Finance/CFO

Corporate Officer/Principal

Corporate Officer/Principal

Medical Specialties

Mark Goldberg

Jeffrey Albers

Linda Bain

Tracey McCain

Christina Rossi

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Director of Finance/CFO

General Counsel

Corporate Officer/Principal

Investment Managers

Abbie Celniker

Jeffrey Walsh

Nick Leschly

Cary Pfeffer

Michelle Doig

Private Equity Investor

Private Equity Investor

Private Equity Investor

Private Equity Investor

Private Equity Investor

Massachusetts Institute of Technology College/University

Lamberto Andreotti

Noubar Afeyan

William R. Sellers

Marcela Maus

Philina Lee

Graduate Degree

Director/Board Member

Corporate Officer/Principal

Corporate Officer/Principal

Doctorate Degree

ELI LILLY AND COMPANY Pharmaceuticals: Major

Freda Lewis-Hall

Martin Babler

Sara Bonstein

Denice Torres

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

AGIOS PHARMACEUTICALS, INC. Pharmaceuticals: Major

David Schenkein

Paul Clancy

Nick Leschly

Andrew Hirsch

Director/Board Member

Director/Board Member

Corporate Officer/Principal

Director of Finance/CFO

College/University

Jay Duker

Catherine Friedman

William R. Sellers

Marcela Maus

Undergraduate Degree

Undergraduate Degree

Corporate Officer/Principal

Corporate Officer/Principal

EXACT SCIENCES CORPORATION Medical Specialties

Freda Lewis-Hall

Noubar Afeyan

Paul Clancy

Jeffrey Walsh

Director/Board Member

Founder

Director/Board Member

Corporate Officer/Principal

Stanford University College/University

Samuel D. Waksal

Badreddin Edris

Robert Ross

Jason Keyes

Corporate Officer/Principal

Graduate Degree

Undergraduate Degree

Graduate Degree

Miscellaneous Commercial Services

David Schenkein

Nick Leschly

Martin Babler

Richard Fitzgerald

Director/Board Member

Director/Board Member

Director/Board Member

Chairman

MERCK & CO., INC. Pharmaceuticals: Major

Wendy Dixon

Thomas Cannell

Yuan Xu

Najoh Tita

Sales & Marketing

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Investment Managers

Ronald Renaud

Jeffrey Walsh

Jeffrey Hrkach

Jeffrey Albers

Consultant / Advisor

Consultant / Advisor

Consultant / Advisor

Private Equity Investor

NOVARTIS AG Pharmaceuticals: Major

Abbie Celniker

Jeffrey Hrkach

Sarah Glickman

Yuan Xu

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

ALEXION PHARMACEUTICALS, INC. Pharmaceuticals: Major

Stephen P. Squinto

Abbie Celniker

Paul Clancy

Saqib Islam

Founder

Corporate Officer/Principal

Director of Finance/CFO

Corporate Officer/Principal

ARVINAS, INC. Biotechnology

Wendy Dixon

Stephen P. Squinto

Linda Bain

Director/Board Member

Director/Board Member

Director/Board Member

MORGAN STANLEY Investment Managers

Catherine Friedman

Saqib Islam

Michelle Doig

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

IDENIX PHARMACEUTICALS INC Pharmaceuticals: Major

Robert Dean Prentiss

Ronald Renaud

Charles Rowland

Director of Finance/CFO

Chief Executive Officer

Director/Board Member

Investment Managers

Vincent Ossipow

Otello Stampacchia

Michelle Doig

Private Equity Investor

Founder

Private Equity Investor

INFINITY PHARMACEUTICALS, INC. Pharmaceuticals: Major

Christopher M. Lindblom

Martin Babler

Michael Landsittel

Comptroller/Controller/Auditor

Director/Board Member

Corporate Officer/Principal

Miscellaneous Commercial Services

Anthony Boral

William R. Sellers

Becker Hewes

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Miscellaneous Commercial Services

Sandra Leung

Charles Sigal

Jan van de Winkel

Director/Board Member

Director/Board Member

Chief Tech/Sci/R&D Officer

MEAD JOHNSON NUTRITION CO Food: Meat/Fish/Dairy

Sandra Leung

Charles Sigal

Lamberto Andreotti

Director/Board Member

Director/Board Member

Director/Board Member

OREXIGEN THERAPEUTICS, INC. Pharmaceuticals: Major

Wendy Dixon

Thomas Cannell

Jason Keyes

Director/Board Member

Chief Operating Officer

Director of Finance/CFO

Pharmaceuticals: Major

Wendy Dixon

Nick Leschly

Cary Pfeffer

Director/Board Member

Director/Board Member

Director/Board Member

University of Michigan College/University

Michael Landsittel

Denice Torres

Janet Loesberg

Undergraduate Degree

Masters Business Admin

Doctorate Degree

Columbia Law School College/University

Jason Cole

Saqib Islam

Tracey McCain

Graduate Degree

Graduate Degree

Graduate Degree

PTC THERAPEUTICS, INC. Pharmaceuticals: Major

Ronald Renaud

Chip Baird

Kathryn Haviland

Director/Board Member

Director of Finance/CFO

Corporate Officer/Principal

CEREVEL THERAPEUTICS HOLDINGS, INC. Pharmaceuticals: Major

Deval Patrick

Ronald Renaud

Paul Burgess

Director/Board Member

Chief Executive Officer

Corporate Officer/Principal

Tufts University College/University

Samuel D. Waksal

Sandra Leung

Peter R. Dolan

Corporate Officer/Principal

Undergraduate Degree

Chairman

Hospital/Nursing Management

Samuel D. Waksal

Jay Duker

David Schenkein

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Corporate Officer/Principal

Tuck School of Business at Dartmouth College/University

Peter R. Dolan

Andrew Hirsch

Michael Landsittel

Masters Business Admin

Masters Business Admin

Masters Business Admin

Georgetown University College/University

Jeffrey Albers

John Agwunobi

William R. Sellers

Graduate Degree

Masters Business Admin

Undergraduate Degree

Harvard Business School College/University

Kathryn Haviland

Christina Rossi

Masters Business Admin

Masters Business Admin

FORTRESS BIOTECH, INC. Pharmaceuticals: Major

Eric Rowinsky

Elisabeth Leiderman

Director/Board Member

Corporate Officer/Principal

LYELL IMMUNOPHARMA, INC. Biotechnology

Lynn Seely

Catherine Friedman

Chief Executive Officer

Director/Board Member

University of California San Diego College/University

Lynn Seely

Abbie Celniker

Corporate Officer/Principal

Undergraduate Degree

Harvard College College/University

Deval Patrick

Mark Goldberg

Undergraduate Degree

Undergraduate Degree

Pharmaceuticals: Major

Eric Rowinsky

Paul Clancy

Director/Board Member

Director of Finance/CFO

New York University School of Medicine College/University

Eric Rowinsky

Steven H. Bernstein

Corporate Officer/Principal

Doctorate Degree

Indiana University College/University

David Krane

Jeffrey Albers

Undergraduate Degree

Undergraduate Degree

VERASTEM, INC. Biotechnology

Eric Rowinsky

Gina Consylman

Director/Board Member

Director/Board Member

Miscellaneous Commercial Services

Mark Goldberg

Jeffrey Albers

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

NAVIDEA BIOPHARMACEUTICALS, INC. Medical Specialties

Eric Rowinsky

Thomas Klima

Chairman

Corporate Officer/Principal

Statistieken

Internationaal

Verenigde Staten 48
Zwitserland 3
Noorwegen 2

Sectoraal

Health Technology 24
Consumer Services 16
Finance 7
Commercial Services 5
Consumer Non-Durables 2

Operationeel

Director/Board Member 564
Corporate Officer/Principal 294
Independent Dir/Board Member 199
Chairman 92
Chief Executive Officer 88
  1. Beurs
  2. Insiders
  3. Daniel Lynch
  4. Bedrijfsconnecties
-40 % Aanbod van beperkte duur: onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU